Special Report on Deposit and Actual Use of Raised Funds
Filed with SSE · · 11 pages · Chinese
Summary by 6ix AI
This filing is a special report on the deposit and actual use of raised funds by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, detailing the management and utilization of funds raised through a stock issuance. It outlines the basic situation of the raised funds, including their storage and actual usage for investment projects and operational needs. The report also discusses any changes in the use of funds and issues related to their management and disclosure. The conclusion from the sponsoring institution confirms compliance with regulations regarding the management of raised funds.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix
Earlier from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Change of Sponsor Representative for Continuous Supervision
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Implementation of Quarterly Dividend Distribution for 2025
- Announcement on Appointment of Senior Management Member
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Later from Tianjin Pharmaceutical Da Ren Tang
- Announcement on Adding Provisional Proposal at the 2025 Annual General Meeting
- Announcement on Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025 and "Corporate Value and Return Enhancement" Action Plan 2026
- Indicative Announcement on Convening the 2025 Annual General Meeting
- Announcement on Resolutions of the 2025 Annual General Meeting
- Indicative Announcement on Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.'s Proposed Public Solicitation of a Transferee for 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd.
Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.
Follow Tianjin Pharmaceutical Da Ren Tang